Addiction

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States – Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission

Open-label exposure trial expected to initiate in Q2’24 with NDA filing anticipated in 1H 2025SEATTLE and VANCOUVER, British Columbia, Feb....

Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement

$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds...

Safe Supply Commends B.C. Naturopathic Doctors Association’s Effort to Expand Prescription Powers Amid Substance-Use Crisis and Provides Update on Safety Strip Acquisition Transaction Details

error: Content is protected !!